ProfileGDS4132 / 202187_s_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 88% 85% 88% 88% 89% 91% 89% 91% 91% 91% 92% 90% 91% 94% 91% 91% 91% 89% 90% 92% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101369.20188
GSM201543Muscle PCOS pioglitazone 121310.44785
GSM201544Muscle PCOS pioglitazone 161417.28288
GSM201545Muscle PCOS pioglitazone 201425.23888
GSM201829Muscle PCOS pioglitazone 231424.71989
GSM201830Muscle PCOS pioglitazon 251445.01191
GSM201831Muscle PCOS pioglitazone 271401.81989
GSM201832Muscle PCOS pioglitazone 31454.15991
GSM201833Muscle PCOS pioglitazone 41486.48991
GSM201834Muscle PCOS pioglitazone 81488.86391
GSM201835Muscle PCOS after pioglitazone 102534.54892
GSM201836Muscle PCOS after pioglitazone 122468.34290
GSM201837Muscle PCOS after pioglitazone 162495.51691
GSM201838Muscle PCOS after pioglitazone 202705.47494
GSM201839Muscle PCOS after pioglitazone 232477.36791
GSM201840Muscle PCOS after pioglitazone 252498.76791
GSM201841Muscle PCOS after pioglitazone 272492.36991
GSM201842Muscle PCOS after pioglitazone 32394.88689
GSM201843Muscle PCOS after pioglitazone 42460.40490
GSM201844Muscle PCOS after pioglitazone 82539.6192